Insider · CIK 0001605767

Bazemore Todd

Reports to the SEC for 3 companies · ARLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001605767

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-22	KALAKALA BIO, Inc.S Sale	Director	SSale	−47.8K sh	$0.83	−$39.6K	35,932
2025-08-29	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2025-06-24	KALAKALA BIO, Inc.S Sale	Director	SSale	−4,058 sh	$4.01	−$16.3K	83,699
2025-06-03	KALAKALA BIO, Inc.S Sale	Director	SSale	−3,390 sh	$3.74	−$12.7K	87,757
2025-03-07	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45.2K sh	—	—	45,200
2025-01-06	KALAKALA BIO, Inc.A Award	Director	AAward	+10.1K sh	—	—	—
2025-01-06	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45.2K sh	—	—	45,200
2025-01-06	KALAKALA BIO, Inc.S Sale	Director	SSale	−1,993 sh	$7.63	−$15.2K	—
2024-06-26	KALAKALA BIO, Inc.S Sale	Director	SSale	−4,653 sh	$4.75	−$22.1K	83,040
2024-05-31	KALAKALA BIO, Inc.S Sale	Director	SSale	−2,093 sh	$6.09	−$12.7K	87,693
2024-01-04	KALAKALA BIO, Inc.A Award	Director	AAward	+6,500 sh	—	—	—
2024-01-04	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.3K sh	—	—	29,300
2024-01-04	KALAKALA BIO, Inc.S Sale	Director	SSale	−1,405 sh	$6.74	−$9,469.7	—
2023-06-22	KALAKALA BIO, Inc.A Award	Director	AAward	+48.7K sh	—	—	84,691
2023-06-22	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+64.9K sh	—	—	64,931
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,439 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,499 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−499 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc.A Award	Director	AAward	+21.2K sh	—	—	35,993
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−864 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,759 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,199 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,400 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,499 sh	—	—	0
2023-03-14	KALAKALA BIO, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+576 sh	—	—	576
2023-01-26	PULMPulmatrix, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,700 sh	—	—	1,700
2023-01-04	KALAKALA BIO, Inc.S Sale	Director	SSale	−62 sh	$28.54	−$1,769.48	14,835
2023-01-04	KALAKALA BIO, Inc.A Award	Director	AAward	+12.8K sh	—	—	14,897
2022-10-26	KALAKALA BIO, Inc.S Sale	Director	SSale	−214 sh	$6.51	−$1,393.14	2,097
2022-06-27	KALAKALA BIO, Inc.S Sale	Director	SSale	−3,092 sh	$0.37	−$1,144.04	115,499
2022-01-27	PULMPulmatrix, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.1K sh	—	—	22,100
2022-01-04	KALAKALA BIO, Inc.S Sale	Director	SSale	−3,454 sh	$1.30	−$4,490.2	118,591
2022-01-03	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+238K sh	—	—	238,000
2021-10-26	KALAKALA BIO, Inc.S Sale	Director	SSale	−12.5K sh	$1.80	−$22.6K	122,045
2021-06-28	KALAKALA BIO, Inc.S Sale	Director	SSale	−2,911 sh	$5.77	−$16.8K	—
2021-01-28	PULMPulmatrix, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-01-04	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+110K sh	—	—	110,000
2021-01-04	KALAKALA BIO, Inc.A Award	Director	AAward	+27.5K sh	—	—	137,500
2020-10-26	KALAKALA BIO, Inc.A Award	Director	AAward	+81K sh	—	—	110,000
2020-10-22	KALAKALA BIO, Inc.P Purchase	Director	PPurchase	+40 sh	$7.60	+$304	42
2020-10-01	PULMPulmatrix, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-06-25	KALAKALA BIO, Inc.A Award	Director	AAward	+19K sh	—	—	29,000
2020-06-05	KALAKALA BIO, Inc.P Purchase	Director	PPurchase	+2 sh	$13.39	+$26.78	2
2020-03-16	KALAKALA BIO, Inc.P Purchase	Director	PPurchase	+10K sh	$5.75	+$57.5K	10,000
2020-01-02	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+120K sh	—	—	120,000
2019-10-12	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+175K sh	—	—	175,000
2019-01-02	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+175K sh	—	—	175,000
2018-02-07	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-11-20	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+172K sh	$19.60	+$3.37M	172,000
2016-01-22	DYAX CORPStock Option (right to buy)D Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−193K sh	—	—	0

Recent filings

Accepted (ET)
Oct 244
Bazemore Todd0001605767-25-000004
SEC(opens sec.gov)
Sep 24
Bazemore Todd0001104659-25-086367
SEC(opens sec.gov)
Jun 264
Bazemore Todd0001415889-25-018319
SEC(opens sec.gov)
Jun 44
Bazemore Todd0001415889-25-015679
SEC(opens sec.gov)
Mar 104
Bazemore Todd0001415889-25-007598
SEC(opens sec.gov)
Jan 74
Bazemore Todd0001415889-25-001062
SEC(opens sec.gov)
Jun 274
Bazemore Todd0001415889-24-018377
SEC(opens sec.gov)
Jun 34
Bazemore Todd0001415889-24-015226
SEC(opens sec.gov)
Jan 54
Bazemore Todd0001415889-24-000766
SEC(opens sec.gov)
Jun 234
Bazemore Todd0001415889-23-010283
SEC(opens sec.gov)
Jun 24
Bazemore Todd0001415889-23-009134
SEC(opens sec.gov)

Companies

Address

C/O KALA BIO, INC. 1167 MASSACHUSETTS AVENUE

ARLINGTON, MA, 02476